Table 2.

Proportion of patients with myeloproliferative disorders who have elevated neutrophil CD177 mRNA levels

Disorder	Increased with CD177 levels (%)	References
Polycythemia vera	95%, 69%, 91%, 100%	[5,26,29,31]
Essential thromobocythemia	21%, 100%, 17%, 67%, 33%	[5,26,29-31]
Idiopathic myelofibrosis	67%	[26]
Chronic myelogenous leukemia	0%	[5]